In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae

International Journal of Antimicrobial Agents

Volumn 19, Issue 1, 2002, Pages 71-74

  Dhople, Arvind M ^a  

^a Florida Institute of Technology   (United States)

Author keywords

Dapsone; Epiroprim; Leprosy; Mouse footpad; Mycobacterium leprae

Indexed keywords

DAPSONE; DIHYDROFOLATE REDUCTASE; EPIROPRIM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FEMALE; FOOT PAD; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LEPROSY; MICROBIAL GROWTH; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ARMADILLOS; DAPSONE; DRUG SYNERGISM; FEMALE; FOLIC ACID ANTAGONISTS; LEPROSTATIC AGENTS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM LEPRAE; TRIMETHOPRIM;

EID: 0036159041     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00470-8     Document Type: Article

References (17)

1. The promin treatment of leprosy: A progress report
2. Two and a half years experimental work on the sulfone groups of drugs
3. Remaining challenges towards the elimination of leprosy
4. Drug resistance in leprosy
5. Studies on risk of leprosy relapses in China: Relapses after treatment with multidrug therapy
6. Relapses as histoid leprosy after receiving multidrug therapy (MDT): A report of three cases
7. Trimethoprim, a sulfonamide potentiator
8. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot pads
9. Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone
10. In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae
11. The use of rodent models in assessing antimicrobial activity against Mycobacterium leprae
12. Limited in vitro multiplication of Mycobacterium leprae
13. A guide to the counting of mycobacteria in clinical and experimental materials
14. The experimental disease that follows the injection of human leprosy bacilli into footpads of mice
15. New antifolate 4,4′-diaminodiphenyl sulfone substituted 2,4-diamino-5-benzylpyrimidines. Proof of their duel mode of action
16. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae